Latest filing published 23 Mar 2026 for Neuronetics, Inc..
Filing timeline
BuySaleInsider track record
Daniel L. Reuvers: trading record in brief
Daniel L. Reuvers (chief executive) discloses dealings in 3 companies, chiefly Integra Lifesciences Holdings Corp, Tactile Systems Technology Inc and Neuronetics, Inc. Over a trading history stretching from 25 March 2013 to 23 March 2026, the count stands at 108 filings.
On the market, this insider has only sold: 23 sales, €2.7M in total. Besides market trades, the filings include 77 share grants and 4 option exercises.
Most recently, on 23 March 2026, the filings show a share grant in Neuronetics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Daniel L. Reuvers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500,000 shares0Common StockSEC:0001563602-26-000006:0
- 68,162 shares0Common StockSEC:0001437749-25-007530:1
- 68,162 shares0Common StockSEC:0001437749-25-007530:0
- 28,338 shares@ US$14.180653.5% of flowCommon StockSEC:0001437749-25-005481:0
- 10,938 shares@ US$14.5513.8% of flowCommon StockSEC:0001437749-25-004938:1
- 15,853 shares0Common StockSEC:0001437749-25-004938:0
- 1,396 shares@ US$15.251.8% of flowCommon StockSEC:0001437749-24-006205:1
- 4,689 shares@ US$15.609.4% of flowCommon StockSEC:0001437749-24-006205:0
- 44,930 shares0Common StockSEC:0001437749-24-005784:1
- 13,100 shares0Common StockSEC:0001437749-24-005784:2
- 6,239 shares@ US$15.818.3% of flowCommon StockSEC:0001437749-24-005784:3
- 5,378 shares@ US$14.84810.3% of flowCommon StockSEC:0001437749-24-005784:0
- 72,046 shares0Common StockSEC:0001437749-24-005438:0
- 1,062 shares@ US$20.53452.8% of flowCommon StockSEC:0001437749-23-022794:0
- 6,387 shares@ US$15.278.4% of flowCommon StockSEC:0001437749-23-004978:1
- 700 shares@ US$14.560.9% of flowCommon StockSEC:0001437749-23-004978:2
- 6,482 shares0Common StockSEC:0001437749-23-004978:0
- 52,613 shares0Common StockSEC:0001437749-23-004565:0
- 1,020 shares@ US$9.18011.3% of flowCommon StockSEC:0001437749-22-019830:0
- 877 shares@ US$19.781.4% of flowCommon StockSEC:0001437749-22-004756:1
- 53,937 shares0Common StockSEC:0001437749-22-004756:0
- 1,063 shares@ US$43.11215.4% of flowCommon StockSEC:0001437749-21-019032:0
- 2,961 shares@ US$49.753417.4% of flowCommon StockSEC:0001437749-21-016567:0
- 7,267 shares0Common StockSEC:0001437749-21-004705:0
- 10,178 shares0Common StockSEC:0001437749-20-017140:0
25 of 101 declarations
